Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MELOXICAM USP, with a corresponding US DMF Number 17358.
Remarkably, this DMF maintains an Active status since its submission on May 05, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 01, 2017, and payment made on January 10, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II